Intelligence Platform
Patents
Browse 126 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 9173896
RNAi-mediated inhibition of connexin 43 for treatment of IOP-related conditions
granted patentUS 9150862
siRNA targeting VEGFA and methods for treatment in vivo
granted patentUS 9139833
Modified small interfering RNA molecules and methods of use
granted patentUS 9139834
RNAi-related inhibition of TNF alpha signaling pathway for treatment of ocular angiogenesi
granted patentUS 9133462
dsRNA for treating viral infection
granted patentUS 9114152
Transferrin/transferrin receptor-mediated siRNA delivery
granted patentUS 9107957
Peptide-based in vivo siRNA delivery system
granted patentUS 9096637
Organic compositions to treat HSF1-related diseases
granted patentUS 9089611
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
granted patentUS 9084808
Modified small interfering RNA molecules and methods of use
granted patentUS 9080175
Organic compositions to treat Beta-ENaC-related diseases
granted patentUS 9074212
RNAi inhibition of alpha-ENaC expression
granted patentUS 9011919
Compositions for targeted delivery of siRNA
granted patentUS 8946176
Compositions and methods for inhibiting expression of RRM2 genes
granted patentUS 8932572
Poly(vinyl ester) polymers for in vivo nucleic acid delivery
granted patentUS 8933047
Poly(acrylate) polymers for in vivo nucleic acid delivery
granted patentUS 8809293
Compositions and methods for inhibiting gene expression of hepatitis B virus
granted patentUS 8802773
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
granted patentUS 8765817
Selective inhibitors of EG5 motors and methods of use
granted patentUS 8715529
Synthesis and applications of triazaborolopyridinium compounds and substituted triazaborol
granted patentUS 8658211
Polyconjugates for in vivo delivery of polynucleotides
granted patentUS 8541548
Compounds and methods for reversible modification of biologically active molecules
granted patentUS 8501930
Peptide-based in vivo siRNA delivery system
granted patentUS 8426554
In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
granted